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Wrch-1, an atypical and transforming Rho GTPase, regulates cellular activities including proliferation and
actin organization, but its functions and effectors remain poorly characterized. We show here that Wrch-1
distributes along the apical and basolateral membranes in MDCK cells and binds the cell polarity protein Par6
in a GTP-dependent manner. Activated Wrch-1 negatively regulates the kinetics of tight junction (TJ) assembly
during epithelial cell polarization but has no detectable effect on overall cell polarity in confluent monolayers.
It also causes a dramatic cytoskeletal reorganization and multilayering in cells grown in two-dimensional
culture and disrupts cystogenesis of cells grown in three-dimensional (3D) culture. Similarly, short hairpin
RNA-mediated knockdown of Wrch-1 perturbs cystogenesis in 3D culture, suggesting that tight regulation of
Wrch-1 activity is necessary for normal epithelial morphogenesis. A weakly transforming effector domain
mutant of activated Wrch-1 that inhibits Par6 binding abrogates the ability of Wrch-1 to disrupt TJ formation,
actin organization, and epithelial morphogenesis. We hypothesize that Wrch-1-induced morphological and
growth transformation may occur in part through Par6-mediated disruption of TJs and actin organization.
Rho family small GTPases are Ras-related proteins that
regulate many normal cellular properties such as cell shape,
cell motility and migration, gene transcription, and cell prolif-
eration (10). Like other members of the Ras superfamily, Rho
GTPases function as molecular switches cycling between an
active GTP-bound state and inactive GDP-bound state (44).
When GTP bound and active, they elicit biological functions
through interactions with their downstream effectors (16).
Wrch-1 is an atypical member of the Cdc42 subgroup of Rho
GTPases that are perhaps best known for inducing the forma-
tion of actin microspikes and filopodia. Wrch-1 shares 57%
sequence identity with Cdc42 and 61% sequence identity with
its close relative, Chp/Wrch-2 (3, 45). Despite this high se-
quence identity, Wrch-1 has unique characteristics that suggest
regulation and biological functions divergent from those of
each of these relatives. For example, Wrch-1 was initially dis-
covered as a Wnt1-responsive gene that, when mutationally
activated (Q107L, analogous to the Q61L mutation in Ras and
Cdc42), phenocopied Wnt-1 morphological transformation
(45). Recent studies have highlighted an additional role for
Wrch-1 in the regulation of cell migration through mechanisms
clearly distinct from those of Cdc42, such as modulating focal
adhesion turnover (8, 30). In addition, Wrch-1 contains a 46-
amino-acid N-terminal extension not found in Cdc42. This
extension contains poly-proline PxxP binding motifs that facil-
itate interactions with Src homology 3 (SH3) domain-contain-
ing proteins such as Grb2, phospholipase C, and NCK (39,
42). We and others have shown that expression of activated
Wrch-1 leads to activation of PAK1 and Jun N-terminal pro-
tein kinase (JNK), formation of filopodia, and cellular trans-
formation of NIH 3T3 fibroblasts (5, 39). Although some of the
biochemical characteristics, subcellular localization, and mem-
brane association properties of Wrch-1 have been identified,
full identification and characterization of Wrch-1 downstream
effectors, regulators, biological functions, and potential contri-
butions to cancer remain elusive.
A yeast two-hybrid screen using Wrch-1 as the bait identified
two proteins as potential interacting partners: Par6 and PAK1b
(4). Par6 is known to form an evolutionarily conserved complex
with protein kinase C  (PKC ) and Par3 that is instrumental
in establishing epithelial cell polarity and in regulating tight
junction (TJ) formation (14, 41). This suggested the possibility
that Wrch-1 might have similar functions and thus share a
critical role in many aspects of normal cell and tissue ho-
meostasis. Classic Rho GTPases, including Rac1 and Cdc42,
are known to participate in the formation of TJs through in-
teractions with the cell polarity proteins Par6 and Par3. Aber-
rant activation of these GTPases is known to disrupt TJs and
cell polarity and to induce epithelial cell transformation (7, 17,
18, 33, 36). Whether Wrch-1 or other atypical Cdc42-related
proteins also participate in TJ regulation or cause transforma-
tion of epithelial cells remains to be tested.
The ability of Rho GTPases to regulate actin cytoskeletal
dynamics is another factor that regulates TJ dynamics and
integrity (6, 27). In epithelial cells, the actin cytoskeleton is
enriched at the apical surface and forms a contractile ring
anchored to adherens junctions (AJs) and TJs which is re-
quired to maintain proper epithelial cell shape and function.
Actomyosin-based contraction of both this actin ring and an
array of basal stress fibers occurs during processes such as cell
polarization and epithelial morphogenesis. Anchoring of the
actin cytoskeleton to cell junctions integrates cell-cell contacts
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with changes in cell morphology and with morphogenetic
movements of epithelial cells that occur during organogenesis
(21). Whether Wrch-1 regulation of the actin cytoskeleton is a
potential mechanism for modulating epithelial cell morphol-
ogy remains to be determined.
One of the earliest steps of tumor initiation and progression
in epithelial cells is the loss of their polarized morphology,
which is a process that involves the loss of cell-cell adhesions,
loss of cell polarization, and reorganization of the cytoskele-
ton. Together, these changes promote dedifferentiation and
are also required for later invasion and metastasis (38). Mis-
regulation of Rho GTPases has been shown to lead to aberrant
growth, dedifferentiation, invasion, and metastasis (9). Wrch-1
message is differentially expressed in a variety of human tu-
mors (20), suggesting that its aberrant function may also con-
tribute to oncogenesis. Whether Wrch-1 expression or activa-
tion contributes to tumorigenesis or other disease pathologies
is unknown.
In the present study, we sought to determine whether
Wrch-1 regulates epithelial cell morphology through modulat-
ing TJs, cell polarity, and the actin cytoskeleton and whether
the loss of normal cell morphology contributes to Wrch-1-
mediated transformation. Specifically, we investigated a poten-
tial interaction between Wrch-1 and the cell polarity protein
Par6 and we used polarized epithelial cells to elucidate
whether expression of Wrch-1 affects epithelial cell TJ assem-
bly and actin organization. We also investigated whether
any such effects are connected with anchorage-independent
growth, a hallmark of transformation, and with loss of three-
dimensional (3D) morphogenesis, a hallmark of dedifferenti-
ation that is necessary for invasion and metastasis. We dem-
onstrate that Wrch-1 expression is required for epithelial
morphogenesis and that activated Wrch-1 has dramatic effects
on cytoskeletal organization, epithelial morphogenesis, and TJ
assembly. These observations reveal a potential mechanism by
which Wrch-1 may control normal cell morphology and con-
tribute to Wrch-1-mediated transformation of epithelial cells.
MATERIALS AND METHODS
Cell culture, transfection, and retroviral infection. COS-7 cells were grown in
Dulbecco’s modified Eagle’s medium (GIBCO/Invitrogen) supplemented with
10% fetal bovine serum (Sigma) and 1% penicillin-streptomycin and maintained
in 5% CO2 at 37°C. Cells were transfected using TransIT-LT1 (Mirus) according
to the manufacturer’s instructions.
MDCKII cells, generously provided by Robert Nicholas (University of North
Carolina—Chapel Hill [UNC-CH]), were grown as described above and supple-
mented with 1% nonessential amino acids (Invitrogen) (“complete medium”).
Stable MDCKII cell lines were generated by retroviral infection. Production of
retrovirus was obtained by CaCl2-mediated transfection of pBabe-HAII-puro,
pVPack-Gag/Pol, and pVPack-Ampho (Stratagene) vectors into 293T cells. Cells
were infected by exposure to retroviral supernatant containing 8 g/ml of Poly-
brene (American Bioanalytical) and maintained in puromycin for 10 days, after
which colonies were pooled for use. MDCKII cell lines stably expressing HuSH
pRS short hairpin RNA (shRNA) (OriGene) vectors were generated by retro-
viral infection as described above. Cystogenic growth in 3D collagen I gels was
performed as described previously (28, 29).
Molecular constructs. Human Wrch-1 proteins (wild type [WT] or Q107L,
N-WT, N-Q107L, and Q107L C255S C256S) were generated as described
previously (5). For hemagglutinin (HA) epitope-tagged Wrch-1, 5 and 3
BamHI sites were introduced by PCR for ligation into the BamHI site of pCGN-
hygro or pBabe-HAII-puro retroviral expression vectors. Human Wrch-1(Q107L
F86C) was generated by site-directed mutagenesis and subcloned as described
above. To generate Myc- and glutathione S-transferase (GST)-tagged human
Par6, PCR was used to introduce 5 BamHI and 3 EcoRI sites into a pBabe-
T7-Par6C construct (gift of Channing Der, UNC-CH) for subcloning into
pCMV3B(Myc) and pGEX4T(GST), respectively. Wrch-1-specific and negative
control noneffective green fluorescent protein (GFP)-directed shRNA expres-
sion vectors were purchased from OriGene. The pRS-shWrch-1 no. 1 plasmid
contains a 29-bp shRNA cassette directed against the Wrch-1 target sequence 5
CAGAGAAGATGTCAAAGTCCTCATTGAG 3, whereas the pRS-shWrch-1
no. 2 plasmid contains a 29-bp shRNA cassette directed against Wrch-1 target
sequence 5 CCGTGAGACTCCAACTCTGTGACACTGCC 3. All sequences
were verified by the Genome Analysis Facility at UNC-CH.
Western blot analysis. Cells were lysed in magnesium lysis buffer (MLB) (25
mM HEPES [pH 7.5], 150 mM NaCl, 1% NP-40, 0.25% Na deoxycholate, 10%
glycerol, 10 mM MgCl2, and complete protease inhibitor tablet [Roche]) or 1%
Triton X-100 containing 1 protease inhibitor cocktail (Roche). Cell lysates
were cleared by centrifugation, and protein concentrations were determined
using the D. C. Lowry protein assay (Bio-Rad). Samples were prepared in 5
sample buffer, and 20 g of protein for each sample was resolved by 12% or 8%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Pro-
teins were transferred to polyvinylidene difluoride (Millipore), blocked overnight
in 3% fish gelatin (Sigma), and incubated with anti-HA (HA.11; Covance),
anti-Myc (9E10; Covance), anti-GST (Covance), and anti--actin (Sigma).
Washed membranes were incubated in anti-mouse or anti-rabbit immunoglob-
ulin G-horseradish peroxidase (Amersham Biosciences) or anti-mouse kappa
light chain-horseradish peroxidase (Zymed), washed again, and developed using
SuperSignal West Dura extended-duration substrate (Pierce).
Reverse transcription-PCR. For reverse transcription-PCR, total RNA was
isolated from MDCK cells using the RNeasy kit (Qiagen). To generate cDNA,
RNA was primed with oligo(dT) primer and reverse transcription was catalyzed
using Superscript III reverse transcriptase (Invitrogen). PCR was performed
using Taq DNA polymerase (Invitrogen) and primers for Wrch-1 (5 CGAG
TACTGAATGCCAGCAA and 3 TGAGCTGGACAAATGCAAAG) and ac-
tin (5 GCTCGTCGTCGACAACGGCTC and 3 CAAACATGATCTGGGT
CATCTT). The resulting product was resolved on a 2% agarose gel and visual-
ized under UV light. Each experiment was run in triplicate, and densitometry
was performed using Image-J software.
GST-pulldown assays and immunoprecipitation. COS-7 cells were lysed 24 h
after transfection in MLB, and the lysates were precleared with GST-Sepharose
beads. Precleared lysates were incubated with GST or GST-Par6C beads. GST-
Par6 was purified as described previously (13). Beads were collected and washed
with MLB and resuspended in sample buffer. SDS-PAGE analysis and immu-
noblotting were performed as described above.
COS-7 cells were lysed 48 h after transfection in MLB. Precleared lysates were
incubated with mouse anti-Myc antibody, and the immunoprecipitates were
collected with protein G Plus-Sepharose beads (Zymed). SDS-PAGE analysis
and immunoblot were performed as described above.
Calcium switch. MDCKII cells were plated on 12-mm Transwell filters (Corn-
ing-Costar) for 4 h in normal calcium medium (NCM; 1.8 mM Ca2). After
attachment, cells were rinsed gently with suspension minimum essential medium
(Gibco/Invitrogen) and then incubated in low calcium medium (LCM; 5 M
Ca2) overnight to disrupt cell-cell contacts. After 18 h, calcium was restored
(calcium switch) by replacement of LCM with NCM.
TER and paracellular permeability assays. To measure transepithelial resis-
tance (TER), MDCKII cells were plated on 12-mm Transwell filters at 5.0  105
cells per cm2 of filter and subjected to calcium switch. TER (	  cm2) was
measured using an epithelial volt-ohmmeter (World Precision Instruments).
Three separate filters were used for each cell line, and the mean resistance was
calculated after subtraction of the background resistance from a filter containing
only culture medium.
Paracellular flux was measured in MDCKII cells subjected to calcium switch.
After incubation in LCM, NCM containing 2 mg/ml of 4,000-kDa fluorescein
isothiocyanate (FITC)-dextran or 40,000-kDa FITC-dextran tracer (Sigma) was
placed in the apical chamber and NCM without tracer was placed in the basal
chamber. Monolayers were incubated in NCM for 6 h at 37°C, and the basal
chamber media was collected. FITC-dextran tracer was measured with a micro-
plate spectrofluorometer (excitation of 492 nm and emission of 520 nm; Spec-
traMax Gemini).
IF analysis. Immunofluorescence (IF) analysis of protein expression and lo-
calization in cells grown on filters was performed as described previously (48).
Briefly, fixed and permeabilized MDCKII cells were incubated overnight in
antibodies to HA (mouse; Covance), zonula occludens 1 (ZO-1; rabbit [Zymed]),
-catenin (rabbit; Sigma), E-cadherin (rat; Sigma), occludin (rabbit); and/or
Par3 (rabbit; Upstate). Cells were then washed and incubated overnight in
secondary antimouse, antirabbit, or antirat antibodies conjugated to Alexa 488,
Alexa 594, or Alexa 647, respectively, and/or with Texas Red-phalloidin (Mo-
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lecular Probes). After antibody treatment, filters were mounted on glass slides
for imaging.
Staining of MDCKII cysts grown in 3D collagen was performed as described
previously (29, 35). Briefly, collagen gels containing MDCKII cells were treated
with collagenase type VII (Sigma C-2399), fixed and permeabilized, and then
incubated in antibodies and mounted for imaging as described above.
Confocal microscopy was performed on an Olympus Fluoview 300 laser-scan-
ning confocal imaging system configured with an IX70 fluorescence microscope
fitted with a PlanApo 60 oil objective. Images were acquired with the use of
Olympus Fluoview software and subsequently resized in Adobe Photoshop. Mul-
tiple xy and xz scans were acquired for each monolayer of cells or 3D collagen gel.
Growth transformation assay. Single-cell suspensions of MDCKII cells (3.5 
103 cells per 35-mm dish) were suspended in 0.4% agar (BD Biosciences) in
complete medium and layered on top of 0.6% agar as described previously (42).
After14days, colonieswerestainedwith3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT; Sigma), and the average number of colonies on
triplicate dishes was calculated.
RESULTS
Wrch-1 interacts with the cell polarity protein Par6 in a
GTP-dependent manner. The function of Rho GTPases is dic-
tated by their subcellular localization and interaction with
downstream effectors. Therefore, the observation that active
GTP-bound Wrch-1 interacts with the cell polarity protein
Par6 in a yeast two-hybrid screen (4) suggested a possible role
for Wrch-1 in regulating cell polarity. To determine whether
GTP–Wrch-1 and Par6 interact in vitro and whether the inter-
action is nucleotide dependent, we expressed Par6 as a GST
fusion protein in E. coli and performed GST-Par6 pulldowns
from lysates of COS-7 cells expressing Wrch-1 proteins. As
predicted by the yeast two-hybrid screen, we found that both
WT and constitutively activated Wrch-1(Q107L) interacted
with GST-Par6 (Fig. 1A) but not with GST-alone controls
(data not shown), whereas GDP-bound Wrch-1(T63N) did not
interact. We also observed that N-terminally truncated N-
Wrch-1(Q107L) still bound to Par6 (Fig. 1A), indicating that
this interaction does not require the polyproline-rich N-termi-
nal extension. To further investigate this interaction, we coex-
pressed the HA-tagged Wrch proteins with Myc-tagged Par6 in
COS-7 cells and assessed their interaction by immunoprecipi-
tation. As predicted by our in vitro GST pulldowns, GTP-
bound WT Wrch-1 or Wrch-1(Q107L) but not GDP-bound
Wrch-1(T63N) associated with imunoprecipitated Par-6 (Fig.
1B). These data show that the cell polarity protein, Par6, as-
sociates with Wrch-1 both in vitro and in vivo in a GTP-
dependent manner, supporting the notion that it could be a
physiological effector of Wrch-1 function.
Wrch-1 localizes to cell-cell junctions in polarized MDCKII
cells. The Par6-PKC  complex regulates the formation of
epithelial cell junctions that are required for normal epithelial
cell polarity and morphology (49), and the interaction of
Wrch-1 with this complex suggested that Wrch-1, like Par6 and
PKC , may also localize at these junctions in polarized cells.
Therefore we used confocal microscopy to visualize Wrch-1
localization in polarized MDCKII epithelial cells stably ex-
pressing HA-tagged Wrch-1 proteins. Wrch-1 localized to the
plasma membrane (PM) and to microvilli at the apical surface,
but was associated predominantly with the basolateral PM
(Fig. 2A). Unfortunately, we were unable to characterize the
distribution of endogenous Wrch-1 in MDCKII because there
is no existing antibody capable of detecting endogenous
Wrch-1.
We then attempted to determine whether Wrch-1 colocal-
izes with components of the polarity complex. Due to the lack
of commercially available antibodies that can effectively detect
Par6 by IF, we used antibodies against Par3, which is known to
associate with both Par6 and PKC  at TJ in polarized
MDCKII cells (15). In empty vector control MDCKII cells,
Par3 was restricted to a defined band at cell-cell contact re-
gions known as the apical junctional complex (AJC) (Fig. 2B,
xz scans). As described above, WT Wrch-1 was distributed all
along the lateral cell contacts but clearly overlapped with en-
dogenous Par3 at the AJC (Fig. 2B). This partial overlap is not
unexpected, because we anticipate that Wrch-1 has multiple
functions in epithelial cells, not all of which are linked to its
interaction with Par6.
The distribution of Wrch-1 predominantly to basolateral
membranes is consistent with its potential association with
cell-cell junctions, such as TJs and AJs. TJs are the most apical
of cell junctions, and TJ proteins such as occludin and ZO-1,
like Par6, are generally restricted to a tight band that circum-
scribes the AJC. AJs are adhesive structures formed through
calcium-dependent interactions between cadherin molecules
on adjacent epithelial cells, and AJ proteins such as E-cadherin
and -catenin localize to both the AJC and along the entire
FIG. 1. GTP-bound Wrch-1 interacts with Par6 in vitro and in vivo.
(A) COS-7 cell lysates expressing empty vector or HA-tagged Wrch-1
constructs were incubated with GST alone or GST-Par6, and the pres-
ence of Wrch-1 in the pulldown was probed by Western blot (immu-
noblot [IB]) analysis with anti-HA antibody. Pulldown of GST-Par6
was confirmed with anti-GST antibody. (B) COS-7 cells were cotrans-
fected with empty vector or HA-tagged Wrch-1 along with Myc-tagged
Par6. Par6 was immunoprecipitated (IP) with anti-Myc antibody, and
immunoprecipitates were probed for Wrch-1 by immunoblotting with
anti-HA antibody.
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lateral PM. To investigate the possibility that Wrch-1 localizes
to both TJs and AJs in polarized epithelial cells, we examined
MDCKII cells stably expressing WT HA–Wrch-1. Wrch-1 lo-
calized at the lateral PM overlapped with the TJ transmem-
brane protein, occludin, and with the TJ peripheral protein,
ZO-1, but did not localize exclusively to TJs (Fig. 3A and B,
top panels). The partial overlap between these proteins at
cell-cell contact regions (Fig. 3A and B, xz scans) suggests that
the spatial distribution of Wrch-1 may allow it to regulate TJs.
We also used IF to investigate the distribution of Wrch-1
relative to the AJ-associated proteins, -catenin and E-cad-
herin. These proteins overlapped with Wrch-1 along the baso-
lateral membrane (Fig. 3C and D, bottom xz panels) and along
the PM at the apical and basal margins of the lateral mem-
brane (Fig. 3C and D, top apical and basal panels). These data
suggest a potential role for Wrch-1 in regulating the structure
and function of AJC by modulating cell junctions (both TJs
and AJs), which are required for proper epithelial cell mor-
phology.
Activated Wrch-1 disrupts TJ formation during cell polar-
ization. Rho GTPases regulate the formation and maintenance
of both TJs and AJs (11, 41). Wrch-1 distribution to cell-cell
junctions and its association with the TJ-associated protein
Par6 suggest that Wrch-1 could regulate TJ formation and
function. Therefore, we generated a large panel of MDCKII
epithelial cells stably expressing HA-tagged Wrch-1 proteins
(Fig. 4A) and used confocal microscopy to investigate the
localization of TJ proteins during calcium-induced cell polar-
ization in the presence or absence of activated Wrch-1. Briefly,
culturing cells in calcium-depleted medium disrupts cell-cell
contacts, and junction proteins are internalized in cytosolic
vesicles. Restoration of calcium (calcium switch) triggers TJ
assembly and cell polarization in a series of kinetically regu-
lated steps. In the absence of calcium (Fig. 4B, 0 h), the
TJ-associated protein ZO-1 was normally localized to a diffuse
perinuclear ring structure that is enriched in actin filaments
(43). Following calcium switch, ZO-1 was redistributed to the
lateral surface of the newly formed cell-cell contacts (Fig. 4B,
FIG. 2. Wrch-1 displays overlapping localization with the cell polarity protein Par3 in polarized MDCKII cells. Cells stably expressing empty
vector or HA-tagged Wrch-1 were grown to confluence on 12-mm Transwell filters and then fixed and stained using primary antibodies against the
HA epitope tag alone (cyan) (A) or either the HA epitope tag (cyan) or Par3 (magenta) (B). IF staining was visualized using a confocal microscope.
Square panels, xy sections; rectangular panels, xz sections (top to bottom). Scale bars, 20 m.
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12 h) in both control cells and cells expressing WT Wrch-1.
This redistribution of ZO-1 is consistent with the formation of
normal TJs.
Strikingly, in cells expressing activated Wrch-1(Q107L), the
diffuse perinuclear accumulation of ZO-1 was missing in the
absence of cell-cell contacts (Fig. 4B, 0 h). Furthermore, fol-
lowing readdition of calcium the movement of ZO-1 to the
AJC was significantly delayed, as indicated by lack of ZO-1 at
the apical surface, and the distribution of ZO-1 within the AJC
at later time points (Fig. 4B, 12 h) was disorganized relative to
cells expressing vector only or WT Wrch-1. This mislocaliza-
tion of ZO-1 is consistent with a delay in proper TJ formation.
However, ZO-1 eventually localized properly to TJs in these
monolayers after 5 days (data not shown), suggesting that it is
the kinetics of TJ formation, and not maintenance of TJ struc-
ture in polarized cells, that is altered by activated Wrch-1.
Activated Wrch-1 disrupts TJ integrity during cell polariza-
tion. The physiological function of TJs, known as the “gate”
function (23), is to form a barrier to the movement of ions and
solutes between cells. The formation of this barrier over time
can be measured by the development of TER, and is a func-
tional measure of TJ assembly. To investigate the role of
Wrch-1 in normal TJ “gate” function, we measured TER de-
velopment in MDCKII cells after calcium switch. In cells ex-
pressing empty vector or WT Wrch-1, TER increased linearly,
reaching an initial peak value at 
18 h before falling to steady-
state levels. In contrast, cells expressing activated Wrch-
1(Q107L) or Wrch-1(N-Q107L) demonstrated altered TER
development, displaying a threefold reduction in peak resis-
tance at 18 h (Fig. 4C). However, the rate of TER development
was unaffected, and steady-state TER levels were identical in
all cell lines by 80 h. Interestingly, expression of an activated
form of Wrch-1 that is mislocalized to the cytosol due to
mutational loss of its C-terminal palmitoylation site, Wrch-
1(Q107L/SSFV), did not delay TER development (Fig. 4C),
suggesting that proper membrane localization of Wrch-1 is
required for its ability to modulate the TJ “gate” function.
Significantly, expression of active, GTP-bound Wrch-1 did
not prevent the eventual formation of a functional TJ seal by

18 h, as indicated by resistance measures above 800 	  cm2.
This is in contrast to constitutively active Ras, which is known
to disrupt cell junctions entirely (25) (Fig. 4C). These data
show that enhanced Wrch-1 activity disrupts TJ “gate” func-
tion only during early TJ assembly, whereas steady state TJ
permeability is unaffected.
The “gate” formed by TJs is not only selectively permeable
to ion flow but also regulates the paracellular flux of hydro-
philic uncharged molecules. Thus, we measured the paracellu-
lar diffusion of FITC-conjugated dextran tracer molecules of
4,000 kDa and 40,000 kDa across cell monolayers. Tracer dif-
FIG. 3. Wrch-1 localizes to cell junctions in polarized MDCK cells. Cells were grown to confluence as described above and then fixed and
probed for the HA epitope tag (cyan) and either occludin (magenta) (A), ZO-1 (magenta) (B), -catenin (magenta) (C), or E-cadherin (magenta)
(D). Square panels, xy sections; rectangular panels, xz sections (top to bottom). Scale bars, 20 m.
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FIG. 4. Activated Wrch-1 disrupts TJ formation and integrity during cell polarization. (A) Equivalent expression in MDCKII cells of indicated
HA-tagged Wrch-1 constructs and H-Ras(Q61L) shown by immunoblot (IB) with anti-HA and anti-Ras antibodies. The loading control was
anti--actin. (B) MDCKII cells stably expressing empty vector or HA-tagged Wrch-1 were grown on 12-mm Transwell filters and subjected to
calcium switch. Cells were fixed at the indicated intervals and stained using primary antibodies against the HA epitope tag (cyan) and ZO-1
(magenta). Square panels, xy sections; rectangular panels, xz sections (top to bottom). Scale bars, 20 m. (C) Cells were subjected to calcium switch
as in panel B. At indicated time points after calcium readdition, TER (	  cm2) was measured using an epithelial volt-ohmmeter. (D) Cells were
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fusion was evaluated 6 h after induction of cell-cell contacts by
the addition of calcium to the apical surface of confluent cell
monolayers grown on filters. As expected, there was minimal
difference in the transcellular diffusion of either tracer in cells
expressing WT Wrch-1 compared to empty vector control cells.
In contrast, we observed a significant enhancement in the dif-
fusion of both dextrans in cells expressing activated Wrch-1 or
Ras (Fig. 4D). As in the TER experiments, the nonpalmitoy-
lated cytosolic mutant of activated Wrch-1(Q107L/SSFV) did
not produce an increase in paracellular flux (Fig. 4D). Simi-
larly, dextran flux in cells expressing activated Wrch-1 was
ultimately normal at 
18 h after calcium switch (Fig. 4D).
Taken together, these data suggest that aberrant activation of
Wrch-1 leads to disruption of early events in TJ assembly and
that other cellular mechanisms capable of regulating TJ dy-
namics compensate at later time points to form a functional TJ.
Activated Wrch-1 disrupts actin organization during cell
polarization and overall cell morphology of MDCKII cells.
There is an intimate relationship between the actin cytoskele-
ton, cell junctions, and epithelial morphogenesis. The dynamic
reorganization of F-actin is closely correlated with changes in
cell structure and the regulation of junction assembly. The loss
of ZO-1-associated perinuclear actin filaments during early
junction assembly led us to hypothesize that Wrch-1 may reg-
ulate actin dynamics during polarization of epithelial cells. To
address this hypothesis, we examined actin organization in
monolayers of cells stably expressing empty vector, WT
Wrch-1, or Wrch-1(Q107L) following calcium switch. As pre-
viously described, in the absence of cell-cell contact, we ob-
served a diffuse cytosolic ring of actin filaments at the apical
surface of MDCKII cells expressing vector or WT Wrch-1 (Fig.
5A, 0 h). This structure was absent in cells expressing activated
Wrch-1(Q107L), and the actin staining was distributed dif-
fusely throughout the cytosol (Fig. 5A, 0 h). After addition of
calcium, the perinuclear actin ring redistributed toward the
PM in cells expressing vector or WT Wrch-1 (Fig. 5A, 15 min)
and subsequently accumulated at cell-cell contacts, as evident
by the intense actin staining between cells (Fig. 5A, 30 min). In
contrast, cells expressing activated Wrch-1(Q107L) still lacked
an actin-rich ring structure, and displayed an apparent de-
creased density of F-actin at the center and periphery (Fig. 5A,
15 and 30 min). Furthermore, F-actin accumulation at cell-cell
contacts was delayed (Fig. 5A, 1 h). These results suggest that
proper cycling of Wrch-1 is required to regulate cytoskeletal
dynamics during junction assembly in epithelia.
These observations led us to examine whether activated
Wrch-1 disrupts normal epithelial cell morphology in mono-
layer culture. Normal monolayers are composed of cuboidal,
columnar epithelial cells with actin-rich microvilli, a contractile
ring of F-actin at the AJC, a cortical array of short actin
filaments on the lateral domain, and actin stress fibers at the
basal surface. Epithelial cells expressing vector or WT Wrch-1
formed normal monolayers of tightly packed cuboidal cells,
and F-actin accumulated in basal stress fibers and within the
AJC. In contrast, cells expressing activated Wrch-1 were squa-
mous, multilayered, and in general more disorganized within
the monolayer (Fig. 5B). This loss of normal cell morphology
was accompanied by the disruption of perijunctional actin bun-
dles normally associated with the AJC (Fig. 5B, apical) and by
disruption of the basal stress fibers (Fig. 5B, basal). Together,
these data show that expression of activated Wrch-1 disrupts
normal epithelial cell morphogenesis and that this loss of nor-
mal cell morphology could be mediated by Wrch-1 modulation
of the actin cytoskeleton.
Coordinate regulation of Wrch-1 binding to Par6 and dis-
ruption of TJs and actin organization during cell polarization.
To determine if the ability of Wrch-1 to disrupt TJ dynamics
and actin organization was linked to the GTP-dependent in-
teraction between Wrch-1 and Par6, we performed site-di-
rected mutagenesis within the effector domain of Wrch-1 to
create a mutant incapable of binding Par6. Previous mutational
analysis of Cdc42 identified a single point mutation at Tyr40 in
the effector domain that was capable of blocking the interac-
tion of active Cdc42-GTP with the CRIB-PDZ cassette of Par6
(13). Therefore, we constructed a point mutation at the anal-
ogous residue of Wrch-1, F86C, to test whether this mutation
would abrogate the GTP-dependent interaction of Wrch-1 and
Par6. Unlike the HA-tagged parental Wrch-1(Q107L), the ef-
fector domain mutant (EDM) Wrch-1(Q107L/F86C) did not
interact with GST-Par6 or immunoprecipitated Myc-Par6 (Fig.
6A and B), as predicted by analogy to the Cdc42 EDM.
We then generated MDCKII cells stably expressing the
Wrch-1 EDM (Fig. 6C) to test the requirement for Par6 or
other CRIB domain-containing proteins in Wrch-1-mediated
modulation of TJ assembly and cytoskeletal dynamics. We
observed that the Wrch-1 EDM did not interfere with correct
localization of ZO-1 during calcium-induced cell polarization
(Fig. 6D). Further, Wrch-1 EDM localization (Fig. 6D) was
distinct from that of activated Wrch-1(Q107L) and instead
resembled that of WT Wrch-1 (Fig. 4B). Expression of the
activated Wrch-1 EDM was also unable to delay initial TER
development (Fig. 6E). Finally, we observed that calcium-in-
duced redistribution of F-actin in the EDM mutant from the
perinuclear network to the AJC was indistinguishable from
WT Wrch-1 (Fig. 6F). These data suggest that the interaction
between Wrch-1 and Par6 may contribute to the localization of
active GTP-bound Wrch-1 and the regulation of TJ assembly
and cytoskeletal dynamics.
Activated Wrch-1 disrupts epithelial morphogenesis and
promotes anchorage-independent growth of MDCKII cells.
Recent studies have highlighted the utility of 3D culture sys-
tems for analysis of epithelial cell polarity and morphology
because they mimic the in vivo formation of epithelial struc-
tures (32, 50). For example, MDCK cells grown in extracellular
matrix form highly polarized structures known as “cysts,” com-
posed of polarized cells whose apical domains surround a hol-
subjected to calcium switch as in panel B. Paracellular flux of 4,000-kDa FITC-dextran (FD-4) or 40,000-kDa FITC-dextran (FD-40) tracer was
examined 6 h and 18 h after calcium switch. RFU, relative fluorescence units. Bar graphs represent an average of three independent experiments
carried out in triplicate for each cell line  standard error of the mean. Significant P values of 0.01 or 0.001 are indicated by * or **,
respectively. Tukey’s multiple comparison test was used to determine significance between cell lines.
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low lumen. To investigate the role of Wrch-1 proteins in epi-
thelial morphogenesis, we grew MDCKII cells in a matrix of
collagen I. Monodispersed cells were grown for 10 days until
they developed into cysts. These cysts were examined using IF
directed against apical and basal polarity determinants such as
ZO-1 and E-cadherin to determine whether apicobasal polar-
ity was established. Cells expressing empty vector or WT
Wrch-1 formed multicellular cysts with a single luminal space
and polarized membrane domains in which ZO-1 was seques-
tered at the apical membrane and E-cadherin along the lateral
membrane (Fig. 7A). In contrast, cysts formed by cells express-
ing activated Wrch-1 contained either multiple minilumens or
no lumen at all. However, individual cells within these highly
disorganized cysts nevertheless retained proper apicobasal po-
larity, with ZO-1 sequestered toward the center and E-cad-
herin localized to the outside of the cysts. Importantly, expres-
sion of the active Wrch-1 mutant that lacks proper membrane
localization did not disrupt normal epithelial cell polarity.
These data suggest that proper epithelial morphogenesis in 3D
requires spatial and/or temporal regulation of Wrch-1 activity.
We next attempted to quantify the degree of cyst lumen
development. In normal cysts, cortical actin staining outlines
FIG. 5. Activated Wrch-1 disrupts actin organization and cell morphology of MDCKII cells. (A) MDCKII cells stably expressing empty vector
or the indicated HA-tagged Wrch-1 constructs were subjected to calcium switch and treated as in Fig. 4B, including probing for the HA epitope
tag (cyan) or with Texas Red-phalloidin (magenta). Asterisks represent actin contractile rings and sites of cell-cell contact. (B) Cells as in panel
A were grown to confluence on 12-mm Transwell filters and then fixed, stained, probed for the HA epitope tag (cyan) or with Texas Red-phalloidin
(red), and visualized by confocal microscopy. Square panels, xy sections; rectangular panels, xz sections (top to bottom). Scale bars, 20 m.
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FIG. 6. An effector domain mutation in Wrch-1 abrogates Par6-binding and its ability to disrupt TJ formation and actin organization during
cell polarization. (A) Lysates from COS-7 cells transiently expressing the indicated constructs including the EDM Wrch-1(Q107L F86C) were
subjected to GST pulldowns as in Fig. 1A. IB, immublotting. (B) Lysates from COS-7 cells expressing the indicated constructs were subjected to
coimmunoprecipitation and immunoblotting as in Fig. 1B. (C) Stable expression in MDCKII cells of HA-tagged Wrch-1(Q107L F86C) was
detected by immunoblotting with anti-HA antibody. Anti--actin was used as a loading control. (D) MDCKII cells stably expressing empty vector
or Wrch-1(Q107L F86C) were subjected to calcium switch, and the localization of Wrch-1 (cyan) and ZO-1 (magenta) was evaluated as in Fig.
4B. Square panels, xy sections; rectangular panels, xz sections (top to bottom). Scale bars, 20 m. (E) TER (	  cm2) was measured in cells
subjected to calcium switch, at indicated time points after calcium readdition. (F) Actin organization was evaluated in cells expressing vector only
or EDM Wrch-1 and subjected to calcium switch. Cells were fixed at indicated intervals after readdition of calcium and stained using either anti-HA
antibody (cyan) or Texas Red-phalloidin (magenta). Asterisks represent actin contractile rings and sites of cell-cell contact.
1043
FIG. 7. Activated Wrch-1 disrupts epithelial morphogenesis and promotes anchorage-independent growth of MDCKII cells. (A) MDCKII cells
stably expressing empty vector or indicated HA-tagged Wrch-1 constructs were grown in collagen I gels. After 10 days, collagen gels were fixed
and stained for ZO-1 (cyan) and E-cadherin (magenta) (top panels) to examine epithelial cell polarity or with Texas Red-phalloidin (magenta)
(bottom panel) to examine epithelial morphogenesis and lumen formation. Scale bars, 20 m. Cysts containing a single lumen were quantified by
counting cysts with single luminal area as positive and cysts with no lumen as negative. Bar graphs represent an average of three independent
experiments carried out in triplicate for each cell line  the standard error of the mean (SEM). Tukey’s multiple comparison test was used to
determine significance between cell lines. Significant P values of 0.001 are indicated by **. (B) Anchorage-independent growth. MDCKII cells
were seeded into soft agar and analyzed for their ability to induce colony formation. Colonies formed after 14 days were stained and scanned, and
the numbers of small (6 to 15 cells across) and large (15 cells across) colonies were quantified. Images and bar graphs are representative of three
separate experiments carried out in triplicate; shown are averages  SEM. Significant P values of 0.001, obtained by using Tukey’s multiple
comparison test, are indicated by **.
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the cell periphery. Cysts expressing activated Wrch-1 did not
contain defects in the formation of the cortical actin cytoskel-
eton. However, the absence of a luminal structure or the for-
mation of multiple lumens was easily visualized upon staining
these cysts with Texas Red-phalloidin (Fig. 7A). We deter-
mined that the formation of cysts with a single luminal space
was abrogated by two- to threefold upon expression of acti-
vated Wrch-1 and that proper membrane localization was re-
quired for this observation. These data highlight that proper
regulation of Wrch-1 activity is necessary for normal epithelial
morphogenesis in 3D and outline a potential mechanism for
Wrch-1-mediated transformation.
The loss of epithelial cell morphogenesis due to the disrup-
tion of cell junctions is a characteristic of cellular transforma-
tion. Therefore, we next examined the ability of Wrch-1 to
induce anchorage-independent growth, another hallmark of
transformation, by assessing the ability of MDCKII cells stably
expressing Wrch-1 proteins to form colonies in soft agar. We
observed that WT Wrch-1 induced twice as many colonies as
empty vector (Fig. 7B). As predicted, activated full-length and
N-terminally truncated Wrch-1 were more potently transform-
ing than WT Wrch-1, inducing colony numbers fourfold over
empty vector controls (Fig. 7B), and those colonies were sub-
stantially larger in size than those induced by WT Wrch-1.
These data demonstrate that Wrch-1 activity promotes anchor-
age-independent growth. We hypothesize that the difference in
colony size observed between WT and constitutively activated
forms of Wrch-1 is due to disruption of actin organization and
cell-cell contacts by the latter.
The effector domain mutation that blocks Par6 binding ab-
rogates Wrch-1-mediated disruption of epithelial morphogen-
esis and partially impairs anchorage-independent growth. We
hypothesized that the Par6-binding-deficient EDM that failed
to disrupt actin organization or perturb TJs would also be
incapable of disrupting epithelial morphogenesis. In cysts
grown in 3D collagen from cells expressing vector or Wrch-
1(Q107L F86C), epithelial morphogenesis was intact (Fig. 8A)
and ZO-1 was sequestered at the apical surface facing the
lumen, while E-cadherin was localized to the basolateral mem-
brane. These results indicate that Wrch-1-mediated disruption
of epithelial morphogenesis (e.g., Fig. 7A) requires the binding
of a CRIB domain-containing effector such as Par6.
The inability of the EDM to misregulate epithelial morpho-
genesis led us to investigate whether it retained the ability to
induce anchorage-independent growth. Interestingly, this
EDM was only partially defective in growth transformation.
Cells expressing Wrch-1(Q107L F86C) formed small or large
colonies similar to those formed by WT-expressing cells (Fig.
8B) and did not show the increased number of large colonies
characteristic of activated Wrch-1. These data suggest that
formation of the large colonies induced by expression of active,
constitutively GTP-bound Wrch-1 requires another effector
whose binding is not perturbed by the F86C mutation that
impairs Par6 interaction.
Loss of Wrch-1 expression perturbs epithelial morphogen-
esis. We have shown here that ectopic expression of a consti-
tutively active mutant of Wrch-1(Q107L) in MDCKII cells
disrupts TJ dynamics, cytoskeletal organization, and morpho-
genesis and that this disruption represents a potential mecha-
nism by which excess Wrch-1 activity mediates cellular trans-
FIG. 8. Effector domain mutation in Wrch-1 abrogates Wrch-1-
mediated disruption of epithelial morphogenesis and promotion of
anchorage-independent growth of MDCKII cells. (A) MDCKII cells
stably expressing empty vector or HA-tagged Wrch-1(Q107L F86C)
were treated and evaluated as in Fig. 7A. (B) MDCKII cells stably
expressing empty vector, WT Wrch-1, Wrch-1(Q107L), or Wrch-
1(Q107L F86C) were seeded into soft agar and analyzed for their
ability to induce anchorage-independent growth as indicated in Fig.
7B. SEM, standard error of the mean.
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formation. To determine the extent to which endogenous
Wrch-1 is required for normal processes such as epithelial
morphogenesis, we generated MDCK II cell lines expressing
Wrch-1-specific shRNAs to knock down expression of endog-
enous Wrch-1. A significant reduction (
65%) of Wrch-1
mRNA was observed upon the introduction of Wrch-1 shRNA
no. 2 when compared to the negative control non-effective
GFP-directed shRNA or to Wrch-1 shRNA no. 1, which did
not effectively reduce Wrch-1 mRNA (Fig. 9A). Therefore, in
the following experiments we used MDCKII cells expressing
Wrch-1 shRNA no. 1 as an additional negative control. In cysts
grown in 3D collagen from cells expressing GFP-directed
shRNA or the ineffective Wrch-1 shRNA no. 1, in which en-
dogenous Wrch-1 levels were unimpaired, epithelial morpho-
genesis occurred normally (Fig. 9B). In contrast, cysts formed
by MDCKII cells in which endogenous Wrch-1 was reduced
upon expression of Wrch-1 shRNA no. 2 had either no lumen
or multiple small lumens (Fig. 9B). These data indicate that
normal levels of endogenous Wrch-1 are required for normal
epithelial morphogenesis in a 3D culture system capable of
recapitulating the in vivo formation of epithelial structures.
DISCUSSION
Recent studies have described roles for the atypical Rho
GTPase Wrch-1 in actin cytoskeletal organization (39), focal
adhesion formation, and cell motility in nonepithelial cells (8,
30). In the present study, we demonstrate that Wrch-1 is re-
quired for normal epithelial morphogenesis in 3D culture. We
have identified a novel biological function for Wrch-1 in reg-
ulating actin cytoskeletal reorganization that is necessary for
proper epithelial morphogenesis and kinetics of TJ assembly.
We hypothesize that the loss of epithelial morphogenesis seen
here in the presence of excessive Wrch-1 activity contributes to
the ability of constitutively active, GTP-locked Wrch-1 to in-
duce transformation of epithelial cells.
Epithelial morphogenesis is a multistep process that re-
quires regulated adhesion and coordinated cell shape changes
within an epithelium. Proper modulation of the actin cytoskel-
eton is a critical component of these morphogenetic processes.
It was shown previously that expression of activated Wrch-1
mediates actin stress fiber dissolution and cell rounding in
fibroblasts (39). We have demonstrated here that activated
Wrch-1 disrupts several distinct pools of F-actin during
calcium-mediated polarization of MDCKII cells. First, we ob-
served that the actin-rich perinuclear ring present in cells de-
void of contact is missing in cells expressing activated Wrch-1.
This structure redistributes to the PM during junction assem-
bly and polarization and is believed to mediate the movement
of junctional proteins from internal vesicles to the periphery of
the cells (1, 40). Therefore, we hypothesize that it is the dis-
ruption of this cytoskeletal domain by activated Wrch-1 that
disrupts early TJ assembly in MDCKII cells.
Regulation of actin cytoskeleton dynamics by Rho GTPases
has been proposed as a general mechanism for regulation of TJ
assembly during cell polarization (6, 26). Expression of consti-
tutively activated, GTP-locked Wrch-1 disrupted TJ formation
and integrity during cell polarization. Although the rate of
TER development of activated Wrch-1-expressing monolayers
was similar to that of control monolayers, the peak magnitude
of TER was markedly reduced, by mechanisms that are cur-
rently unclear. However, TJs do form eventually in cells ex-
pressing activated Wrch-1, suggesting that initial regulation of
Wrch-1 activation is necessary only for early TJ dynamics and
not for TJ maintenance. These findings are strikingly similar to
the kinetic delay in TJ formation following RNA interference-
mediated knockdown of the tight junction scaffolding protein
ZO-1 (24), where it was proposed that the loss of the perinu-
FIG. 9. Loss of Wrch-1 expression perturbs epithelial morphogen-
esis. (A) mRNA levels of Wrch-1 or actin isolated from MDCKII cells
stably expressing pRS-GFP, pRS-shWrch-1 no. 1 or pRS-shWrch-1 no.
2. Quantification of Wrch-1 mRNA levels was normalized to actin
using ImageJ. Bar graphs represent an average of three independent
experiments for each cell line  the standard error of the mean
(SEM). Tukey’s multiple comparison test was used to determine sig-
nificance between cell lines. Significant P values of 0.001 are indi-
cated by **. (B) MDCKII cells stably expressing pRS-GFP, pRS-
shWrch-1 no. 1, or pRS-shWrch-1 no. 2 were treated and evaluated as
in Fig. 7A.
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clear ring of actin in ZO-1 knockdown cells might inhibit the
delivery of TJ-associated barrier proteins to the cell boundary.
Activated Wrch-1 also perturbed cytoskeletal organization
in confluent monolayers. The sharp, linear band of actin asso-
ciated with AJC and the basal stress fibers were highly disor-
ganized in MDCKII cells expressing activated Wrch-1. These
changes were accompanied by a dramatic alteration in the
organization of these cells within the monolayer and by defects
in cystogenesis of cells grown in 3D collagen matrix. These
observations suggest that Wrch-1 may regulate cytoskeletal
dynamics that underlie tissue morphogenesis in epithelia. It is
not surprising that either constitutive activation or shRNA-
mediated knockdown of Wrch-1 promotes the disruption of
epithelial morphogenesis; rather, these findings are consistent
with a requirement for tightly and correctly regulated Wrch-1
activity to support normal cystogenesis. A similar requirement
for optimal levels of endogenous Cdc42 to promote proper
cystogenesis has been observed in two independent studies that
investigated the effect of RNA interference-mediated knock-
down of Cdc42 or expression of constitutively active or domi-
nant-negative Cdc42 (22, 34). In all cases, misregulation of
Cdc42 resulted in the reduction of normal lumen-containing
cysts, suggesting that tight regulation of members of the Rho
GTPase family is necessary for normal epithelial cell morpho-
genesis.
Indeed, we had initially speculated that the identification of
the polarity complex protein Par6 as a GTP-dependent binding
partner of Wrch-1 suggested a possible role for Wrch-1 in
modulating cell polarity. However, aberrant regulation of
Wrch-1 activity does not affect cell polarity in 3D culture,
suggesting that Wrch-1 interaction with the Par3-Par6-PKC 
complex plays a distinct role from the previously described
regulation by Cdc42. We previously showed that Cdc42 and
Wrch-1 have distinct localizations in fibroblasts (5), and our
present work also suggests that these related GTPases have
divergent localizations in epithelial cells. For example, Cdc42
was shown to localize to the apical surface of MDCK cysts
grown in 3D, and suppression of Cdc42 expression disrupted
normal apicobasal polarity in 3D culture (22). This is distinct
from the basolateral PM localization of Wrch-1 characterized
in this report and our observation that activated Wrch-1 or
reduction of Wrch-1 expression disrupts cell morphology and
cystogenesis without perturbing apicobasal polarity. Therefore,
we hypothesize that both Cdc42 and Wrch-1 regulate the Par3-
Par6-PKC  complex, but at different spatial or temporal do-
mains.
The loss of epithelial cell morphology is characteristic of
dedifferentiated cancer cells that lose normal cell polarity and
cell-cell contacts. Previous studies in this laboratory demon-
strated that activated Wrch-1 promotes anchorage-indepen-
dent growth of NIH 3T3 fibroblasts, a hallmark of oncogenic
transformation (5, 42), and we have shown here that stable
expression of activated Wrch-1 also promotes anchorage-inde-
pendent growth of MDCKII epithelial cells. Recent studies
have highlighted the ability of oncogenes to hijack cell polarity
protein complexes to promote dedifferentiation in the early
stages of epithelial cell carcinogenesis. The Par6-PKC  pro-
tein complex has been identified as a downstream player in the
loss of cell polarity, in epithelial-mesenchymal transition, and
in increased cell proliferation mediated by receptor tyrosine
kinases, including ErbB2, and by transforming growth factor ,
all of which promote cellular transformation and migration (2,
31). However, the exact mechanisms by which misregulation of
cell polarity proteins leads to dedifferentiation and transfor-
mation remain to be determined. It has been shown previously
that transformation mediated by aberrant activation of Cdc42
or Rac can be potentiated by the Par6-PKC  complex (33).
These findings further support a link between the regulation of
cell morphology by Rho GTPases and contact-inhibited
growth.
Our data suggest that Par6 may be one important effector of
activated Wrch-1 in epithelial morphogenesis. This hypothesis
is supported in part by our observation that an EDM of acti-
vated Wrch-1 that cannot bind Par6 is unable to disrupt cell
architecture and cyst formation in MDCKII cells. It is also
supported by the previously published observations that alter-
ations in Par6 expression have many of the same effects on
epithelial morphogenesis as abnormal levels of Wrch-1 activity.
For example, overexpression of Par6 delays TJ assembly in
MDCKII cells (12), and expression of a dominant-negative
form of Par6 in MDCK cells grown in collagen disrupts cysto-
genesis (19).
The most pressing question, then, is how the Wrch-1–Par6
effector complex regulates cytoskeletal dynamics. Chen et al.
recently identified a link between the cell polarity protein Par3
and regulation of actin dynamics important for proper TJ as-
sembly, in which Par3 binds to and inhibits LIMK activity,
leading to a subsequent decrease in cofilin activity (7). There-
fore, we predict that the association between active Wrch-1
and the Par3-Par6-PKC  complex may ultimately alter actin
dynamics through known Rho GTPase effectors such as LIMK.
Despite the similarity in the epithelial phenotypes generated
by Par-6 and Wrch-1 mutations, it is still possible that other
Wrch-1 effectors may be involved. At present, the only other
proteins identified to date whose properties are consistent with
an effector function for Wrch-1 are PAK1 (8, 39) and Pyk2
(37). Pyk2 is a Wrch-1 effector capable of mediating Wrch-1
effects on cytoskeletal dynamics of filopodia and stress fibers.
Pyk2 could represent a relevant effector for Wrch-1-mediated
defects in cystogenesis, because the single F86C point muta-
tion in Wrch-1 was sufficient to block its interaction with Pyk2
or to abolish Wrch-1-mediated loss of stress fibers or formation
of filopodia (37). Unlike Pyk2, the interaction between Wrch-1
and Pak1 is not abrogated by the F86C point mutation, sug-
gesting that Pak1 may not contribute to the biological activ-
ities revealed in this study (30). Understanding the exact
mechanisms whereby Wrch-1 regulates each of these distinct
processes will likely require further investigation of known
Wrch-1 effector targets as well as identification of novel
Wrch-1 effectors.
However, the F86C EDM of Wrch-1 that is incapable of
interacting with Par6 nevertheless retains the ability to weakly
promote anchorage-independent growth, suggesting that other
Wrch-1 effectors must also contribute to Wrch-1-mediated
transformation. As stated above, the interaction between
Wrch-1 and Pak1 is not abrogated by this mutation (30), sug-
gesting that the known interaction with Pak1 may contribute to
Wrch-1-mediated transformation while the activity of Par6 is
more restricted to morphogenesis. Of these two effectors, only
Pak1 has been implicated in promoting anchorage-indepen-
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dent growth (46), and it has been shown to be altered in human
cancers (47). Whether Wrch-1 signaling through Pak1 could
contribute to Wrch-1-mediated transformation bears further
investigation.
Our observations that Wrch-1 can interact with the Par6-
associated polarity complex and can disrupt epithelial cell mor-
phology and cell junctions in a manner that can be abrogated
by blocking Par6 binding suggest a potential mechanism for
Wrch-1-mediated transformation. The identification of the
gene coding for Wrch-1 as a gene whose expression is regu-
lated by Wnt-1 signaling in mouse mammary epithelial cells
and its ability to phenocopy Wnt-1 mediated transformation,
along with aberrant regulation of Wrch-1 expression in various
cancers, suggest the possibility that Wrch-1 may play a role in
human tumorigenesis. Although naturally occurring activating
mutations that lock Wrch-1 in the GTP-bound state have not
been identified, the considerable evidence for a role for other
Rho family GTPases in pathological states also does not in-
clude the discovery of activating mutations in the Rho proteins
themselves but instead involves aberrant activity of their reg-
ulators, the guanine exchange factors and GTPase-activating
proteins that modulate GTP/GDP cycling. Thus, further iden-
tification of its upstream activators, downstream negative reg-
ulators and effector targets will be critical for a fuller under-
standing of the molecular mechanisms and role of Wrch-1 in
transformation.
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